Aclarion, Inc. (Nasdaq: ACON, ACONW) reported that nearly 100 Nociscan procedures have been conducted at The London Clinic, one of the United Kingdom's leading private hospitals. The company released a video featuring Mr. John Sutcliffe, Consultant Spinal Neurosurgeon and Lead Clinician at The London Spine Clinic, discussing his experience with the technology.
Nociscan is a non-invasive diagnostic platform that uses MR spectroscopy and proprietary augmented intelligence algorithms to identify chemical biomarkers associated with painful discs in the lumbar spine. The system helps physicians differentiate between painful and non-painful discs, providing objective data to guide treatment decisions for chronic low back pain.
Mr. Sutcliffe, who has over 30 years of experience treating spinal conditions, noted that Nociscan offers an additional layer of insight beyond traditional imaging. “Having more objective data can help inform clinical decisions and improve confidence when evaluating patients with chronic low back pain,” he said in the video, which is available here.
The continued use of Nociscan at The London Clinic reflects sustained physician engagement and growing integration into routine practice. According to the company, this milestone is an important indicator of increasing adoption. Brent Ness, Chief Executive Officer of Aclarion, stated, “Approaching 100 scans at a leading international center like The London Clinic reinforces the potential for Nociscan to become a valuable tool in the evaluation of chronic low back pain.”
Chronic low back pain affects approximately 266 million people worldwide, presenting a significant global healthcare challenge. Clinical data suggests that when all Nociscan-positive discs are treated, surgical success rates can reach up to 97% when used alongside other diagnostic tools.
To find a Nociscan center, view the site map here. For more information on Nociscan, email info@aclarion.com. The latest news and updates relating to Aclarion are available in the company's newsroom at https://tinyurl.com/aconnewsroom.
